Methenamine
INDICATIONS
FDA
FDA
- Prophylactic or suppressive treatment of frequently recurring urinary tract infections.
- Use after eradication of the infection by other appropriate antibiotics.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 17, 2024
Citation
, , and Edina Avdic. "Methenamine." Johns Hopkins ABX Guide, The Johns Hopkins University, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540344/all/Methenamine.
, Avdic E. Methenamine. Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540344/all/Methenamine. Accessed October 10, 2024.
, ., & Avdic, E. (2024). Methenamine. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540344/all/Methenamine
, Avdic E. Methenamine [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2024. [cited 2024 October 10]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540344/all/Methenamine.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Methenamine
ID - 540344
A1 - ,,
AU - Avdic,Edina,Pharm.D.
Y1 - 2024/08/17/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540344/all/Methenamine
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -